
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what's possible.
The Specialist, Document Management & Training is responsible for supporting the administration and continuous improvement of the document control and training systems within a GMP-regulated environment. This role ensures that controlled documents and training records are accurate, compliant, and maintained in accordance with regulatory requirements and internal procedures.The Specialist will partner cross-functionally to manage document lifecycles, support training compliance, and drive timely completion of training assignments, while contributing to operational excellence and inspection readiness initiatives.
Title: Specialist, Document Management & Training (Contract)
Reports to: Sr. Specialist, Document Management & Training
Location: Remote
Travel: None
Duration: 6+ Months
Hourly Rate: $50–$60/hour

Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis.
Kyverna’s pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.